CrushSCI.com
79.7Average days
64Median days
17Fastest days
207Longest days
4,1292025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

97 days

Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling

Authors
Chenglang Jiang; Weiqi Shen; Xin Liu; Yuhang Hui; Boru HouShow moreShow less
Affiliations
1. The Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , China; 2. Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University , Lanzhou , Gansu , China; 3. Academician Workstation of the Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , ChinaShow moreShow less
Source PDF DOI Publisher page
22 days

Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series

Authors
Yongbao Wei; Huaishan Hong; Dewen Zhong; Ruochen Zhang; Zhixuan Guo; Huang Lin; Jun Lin; Tao Li; Jinfeng Wu; Jianhui Chen; Yi ZhangShow moreShow less
Affiliations
1. Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, China; 2. Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, China; 3. Department of Urology, Fujian Medical University Union Hospital, China; 4. Department of Urology, The Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, ChinaShow moreShow less
Source PDF DOI Publisher page
26 days

Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state

Authors
Eleonora De Paola; Fabrizio Galliccia; Raffaella Maione; Natalia Maria Verrelli; Diego Alejandro DriShow moreShow less
Affiliations
1. Clinical Trials Office, Italian Medicines Agency (AIFA), Italy; 2. Department of Pharmacy, School of Specialisation in Hospital Pharmacy, University of Pisa, ItalyShow moreShow less
Source PDF DOI Publisher page
48 days

Hormophysa cuneiformis protects against methamphetamine-induced hepatotoxicity via antioxidant, anti-inflammatory, and autophagy-regulatory mechanisms: histological and biochemical studies

Authors
Mayada Elhusseiny; Rabab S. El-Kelany; Rania A. El-Shenody; Mohamed S. El-Hashash; Mostafa E. Elshobary; Samar Sami AlkafaasShow moreShow less
Affiliations
1. Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt; 2. Forensic Medicine and Clinical Toxicology at the Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Tanta University, Egypt; 3. Botany and Microbiology Department, Faculty of Science, Tanta University, Egypt; 4. Aquaculture Research, AWI-Helmholtz Centre for Polar and Marine Research, Germany; 5. Molecular Cell Biology Unit, Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, EgyptShow moreShow less
Source PDF DOI Publisher page
50 days

Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression

Authors
Yongliang Zheng; Yuxiu Yang; Shouhua Zhang; Rui Liu; Zujie Lin; Yuanqiao He; Yaoling Luo; Aili HeShow moreShow less
Affiliations
1. Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 2. Department of Hematology, The Affiliated Hospital of Jinggangshan University, China; 3. School of Pharmacy, Jiangxi Science and Technology Normal University, China; 4. Department of General Surgery, Jiangxi Provincial Children’s Hospital, The Affiliated Children’s Hospital of Nanchang Medical College, China; 5. Center of Laboratory Animal Science, Nanchang University, China; 6. Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, China; 7. Clinical Medicine Research Center, First Affiliated Hospital of Gannan Medical University, China; 8. National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 9. Department of Tumor and Immunology, Precision Medical Institute, Xi’an Jiaotong University, China; 10. Xi’an Key Laboratory of Hematological Diseases, ChinaShow moreShow less
Source PDF DOI Publisher page
58 days

Male sexual dysfunction associated with TNF-α inhibitors: an indication-stratified global pharmacovigilance analysis

Authors
Yi Chu; Min Luo; Wenyu Li; Xuehong Wang; Yuqian ZhouShow moreShow less
Affiliations
1. Department of Gastroenterology, The Second Xiangya Hospital of Central South University, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Frontiers in Pharmacology take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for Frontiers in Pharmacology. The fastest paper went from submission to acceptance in 17 days (Bioresponsive gelatin-coated silk fibroin nanoparticles enhance roxadustat therapy in experimental pulmonary fibrosis, received 2026-06-28, accepted 2026-07-15); the slowest took 207 days. The average is 79.7 days and the median is 64 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.